News & Events about Fulcrum Therapeutics Inc.
Fulcrum Therapeutics (NASDAQ:FULC Free Report) and Lyell Immunopharma (NASDAQ:LYEL Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, valuation, dividends, institutional ...
Globe Newswire
3 months ago
BENSALEM, Pa., June 27, 2023 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion. ...
Globe Newswire
3 months ago
NEW YORK, June 27, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Fulcrum Therapeutics, Inc. ("Fulcrum" or the "Company") (NASDAQ: FULC) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Fulcrum investors who were adversely...
Globe Newswire
3 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulcrum Therapeutics, Inc. (Fulcrum or the Company) (NASDAQ: FULC), and certain officers. The class action, filed in the United States District Court for the District of New Jersey...
Globe Newswire
3 months ago
NEW YORK, June 25, 2023 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Edgio, Inc. (NASDAQ: EGIO), Fulcrum Therapeutics, Inc. (NASDAQ: FULC), adidas AG (OTC: ...